Dr. Wei - Lien Wang, MD

Dr. Wang practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Wang's NPI, 1669429023, was assigned on May 30, 2006. Dr. Wang graduated from Tufts University School Of Medicine in 2002. Dr. Wang holds Texas license N2879.

Dr. Wang's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Wang's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Wang is board certified in dermatopathology by the American Board of Pathology. Dmand AI has Dr. Wang's licenses on file in 3 states: Texas, California and Massachusetts.

CMS data shows 543 Medicare services from Dr. Wang across 8 procedure codes in 2024, for 215 Medicare patients. Medicare paid $20,235 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 215 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 58, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 159 papers to Dr. Wang, published from 2009 to 2025. 2017 was the busiest year, with 16. The most frequent topics are Biomarkers, Tumor, Immunohistochemistry and Soft Tissue Neoplasms. Dr. Wang has published most often in Mod Pathol. Dr. Wang's most frequent co-authors are Alexander J.f. Lazar, MD, PhD, Shreyaskumar R. Patel and Behrang Amini, MD, PhD.

CMS Open Payments shows 6 general payments to Dr. Wang from 2 drug and device companies from 2017 to 2019. Travel and lodging make up the largest share, 54% of the total. The Spectranetics Corporation paid the most, $418.

Dr. Wang graduated from Tufts University School Of Medicine in 2002.

Dr. Wang is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.